In vitro effects of palmitylcarnitine on cardiac plasma membrane Na, K-ATPase, and sarcoplasmic reticulum Ca 2+ -ATPase and Ca 2+ transport
GLP-1 drugs were originally developed to treat type 2 diabetes, though when it comes to this condition, the statistics are less encouraging
This article provides a detailed comparison of semaglutide and tirzepatide, including how they work, clinical outcomes, dosing considerations, and access factors, to help patients and healthcare professionals determine which therapy best aligns with specific health goals and preferences
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet